Search
15/12/2025
Early start of opicapone in Parkinson's disease: evidence from a pooled analysis of phase 3 trials for sustained benefit in patients with recent onset of motor fluctuations
Ferreira, JJ, Stocchi, F, Antonini, A, Rascol, O, Ebersbach, G, Kulisevsky, J, Fonseca, MM, Ramos, D, Rocha, JF, Brigas, HC, Holenz, J, Poewe, W. Early start of opicapone in Parkinson's disease: evidence from a pooled analysis of phase 3 trials for sustained benefit in patients with recent onset of motor fluctuations. Frontiers in Neurology. 2025; 16DOI:10.3389/fneur.2025.1715748. PMID:41473225. IF:2.800(Q2/5D).
15/12/2025
Ketamine, Etomidate, and Mortality in Emergency Department Intubations
Maia, IWA, Decker, SRR, Silva, LOJE, von Hellmann, R, Alencar, JCG, Hajjar, LA, de Carvalho, JMD, Pedrollo, DF, Nogueira, CG, Figueiredo, NMP, Miranda, CH, Martins, D, Baumgratz, TD, Bergesch, B, Colleoni, O, Zanettini, J, Freitas, AP, Tambelli, R, Costa, MC, Correia, W, de Maria, RG, , UAV, Weber, AP, Castro, VD, Dornelles, CFD, Tabach, BS, Moreira, NP, Gaspar, PL, Guimaraes, HP, Stanzani, G, Gava, TF, Mullan, A, Brown, CS, Bellolio, F, Jeffery, MM, Ranzani, OT, Besen, BAMP. Ketamine, Etomidate, and Mortality in Emergency Department Intubations. JAMA Network Open. 2025; 8(12)DOI:10.1001/jamanetworkopen.2025.48060. PMID:41396604. IF:9.700(Q1/1D).
15/12/2025
Clinical and immunologic characteristics of nonhematologic autoimmune disorders in chronic lymphocytic leukemia
Arguello-Tomas, M, Lynton-Pons, E, Albiol, N, Lopez-Ferrer, A, Sierra, J, Moga, E, Moreno, C. Clinical and immunologic characteristics of nonhematologic autoimmune disorders in chronic lymphocytic leukemia. CANCER. 2025; 131(24)DOI:10.1002/cncr.70216. PMID:41378669. IF:5.100(Q1/3D).
14/12/2025
Targeting Overtreatment of Asymptomatic Bacteriuria in the Emergency Department: Results from a Quasi-Experimental Clinical Pharmacist-Led Program Based on Education and Audit
Monje, A, Escolà-Vergé, L, Rivera, A, Herrera, S, Plaza, A, Duch-Llorach, P, Pomar, V, Roch, N, Rouras, L, Lopez-Contreras, J, Ramos, JR. Targeting Overtreatment of Asymptomatic Bacteriuria in the Emergency Department: Results from a Quasi-Experimental Clinical Pharmacist-Led Program Based on Education and Audit. Antibiotics-Basel. 2025; 14(12)DOI:10.3390/antibiotics14121261. PMID:41463763. IF:4.600(Q1/2D).
12/12/2025
Clinical recognition of frontotemporal dementia with right temporal predominance: a consensus statement from the International Working Group
Ulugut, H, Younes, K, Montembeault, M, Bertoux, M, Irish, M, Kumfor, F, Fumagalli, GG, Samanci, B, Illán-Gala, I, Thompson, JC, Santillo, AF, Englund, E, Waldö, ML, Riedl, L, van den Stock, J, Vandenbulcke, M, Vandenberghe, R, Laforce, R, Ducharme, S, Pressman, PS, Caramelli, P, de Souza, LC, Takada, LT, Gurvit, H, Diehl-Schmid, J, Galimberti, D, Pasquier, F, Weintraub, S, Miller, BL, Sturm, VE, Whitwell, JL, Boeve, B, Rohrer, JD, Piguet, O, Gorno-Tempini, ML, Josephs, KA, Snowden, J, Rowe, JB, Warren, JD, Rankin, KP, Pijnenburg, YAL. Clinical recognition of frontotemporal dementia with right temporal predominance: a consensus statement from the International Working Group. Communications Medicine. 2025; 5(1)DOI:10.1038/s43856-025-01252-4. PMID:41387629. IF:(Q/D).
11/12/2025
Targeting Atherosclerosis: Cholesterol-Lowering Therapies with a New Immunometabolic Dress for an Old Disease
Julve, J, Rodriguez-Calvo, R, Perret, B, Martinez, LO, Mauricio, D. Targeting Atherosclerosis: Cholesterol-Lowering Therapies with a New Immunometabolic Dress for an Old Disease. Journal of Clinical Medicine. 2025; 14(24)DOI:10.3390/jcm14248777. PMID:41464678. IF:2.900(Q1/2D).